Global Markets
Novo Nordisk's (NOVOB DC) US Head says direct-to-consumer sales represent 90% of Wegovy pill volume, and 30% of injectable volume
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
